Bionor Immuno AS
- Country
- 🇳🇴Norway
- Ownership
- Subsidiary
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.bionorpharma.com
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir
- Conditions
- Interventions
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Bionor Immuno AS
- Target Recruit Count
- 26
- Registration Number
- NCT02092116
- Locations
- 🇩🇰
Aarhus University Hospital, Skejby Sygehus, Aarhus N, Denmark
Re-boosting of HIV-1 Infected Subjects With Vacc-4x
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Bionor Immuno AS
- Target Recruit Count
- 33
- Registration Number
- NCT01712256
- Locations
- 🇺🇸
UC Davis Medical Center, Sacramento, California, United States
🇩🇪EIPMED - Gesellschaft fűr epidemiologische und klinische Forschung in der Medizin mbH Rubensstrasse 125, Berlin, Germany
🇩🇪ifi - Studien und Projekte GmbH, an der Asklepios-Klinik St. George, Hamburg, Germany
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
- Conditions
- Interventions
- First Posted Date
- 2012-10-11
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Bionor Immuno AS
- Target Recruit Count
- 36
- Registration Number
- NCT01704781
- Locations
- 🇩🇪
EIPMED - Gesellschaft fűr epidemiologische und klinische Forschung in der Medizin mbH Rubensstrasse 125, Berlin, Germany
🇩🇪University Medical Center Hamburg-Eppendorf, Hamburg, Germany
🇩🇪Charite Campus, Virchow-Klinikum Medizinische Klinik mit Schwerpunkt Infektiologie Station 59 (Suedring 11) Augustenburger Platz 1, Berlin, Germany
Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2014-01-14
- Lead Sponsor
- Bionor Immuno AS
- Target Recruit Count
- 36
- Registration Number
- NCT01627678
- Locations
- 🇳🇴
Oslo University Hospital, Ullevål, Oslo, Norway
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Bionor Immuno AS
- Target Recruit Count
- 137
- Registration Number
- NCT00659789
- Locations
- 🇩🇪
Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
🇪🇸Hospital Clinic i Provincial, Barcelona, Spain
🇪🇸Hospital Germans Trias i Pujol, Badalona, Spain